Thu, April 11, 2024
Wed, April 10, 2024
Tue, April 9, 2024

Josh Schimmer Reiterated (XENE) at Buy and Held Target at $65 on, Apr 10th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-65-on-apr-10th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Josh Schimmer of Cantor Fitzgerald, Reiterated "Xenon Pharmaceuticals Inc." (XENE) at Buy and Held Target at $65 on, Apr 10th, 2024.

Josh has made no other calls on XENE in the last 4 months.



There are 6 other peers that have a rating on XENE. Out of the 6 peers that are also analyzing XENE, 0 agree with Josh's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Josh


  • Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $55 on, Friday, March 1st, 2024
  • Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $51 on, Friday, March 1st, 2024
  • Serge Belanger of "Needham" Maintained at Strong Buy with Increased Target to $62 on, Friday, March 1st, 2024
  • David Hoang of "Citigroup" Initiated at Strong Buy and Held Target at $62 on, Thursday, January 4th, 2024
  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Increased Target to $56 on, Tuesday, January 2nd, 2024
  • Stephen Willey of "Stifel" Maintained at Strong Buy with Increased Target to $62 on, Monday, December 18th, 2023

Publication Contributing Sources